Bayer, Amgen join $ 120M financing for startup aiming to expand genetic meds delivery

Bayer, Amgen join $ 120M financing for startup aiming to expand genetic meds delivery

ReCode Therapeutics was formed around new science potentially enabling delivery of genetic medicines to various organs in the body, and the startup has encouraging data for its therapeutic candidates targeting the lungs. Now the biotech startup has $ 120 million to show that it can deliver on the technology’s promise in other organs and cell … Read more

Metaverse in healthcare – MedCity News

Metaverse in healthcare – MedCity News

Virtual and augmented reality have been a growing trend in healthcare, with hospitals applying the tech for surgery prep, reducing patient anxiety, and helping patients better understand how a procedure will be done. The virtual world will be part of the upcoming INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented … Read more

Amwell CEO on MedCity Pivot Podcast: Sometimes “we are punished” for biz models that have nothing to do with our approach

Amwell CEO on MedCity Pivot Podcast: Sometimes “we are punished” for biz models that have nothing to do with our approach

It’s the best of times. It’s the worst of times – for telehealth companies, that is. No one category has seen its value in healthcare delivery be proven during the pandemic so much so that the digital transformation of healthcare has catapulted from nice-to-have to must-have. Yet, no other category has seen a reversal of … Read more

Why obesity intervention needs to be a bigger part of chronic disease care

Why obesity intervention needs to be a bigger part of chronic disease care

Obesity has had an overwhelming presence in the US over the past few decades, but the problem has been exacerbated by the pandemic. The latest CDC data shows that 42% of Americans were obese in March 2020. A survey from the American Psychological Association, conducted last year, found that nearly half of Americans said they … Read more

Astellas pays Sutro Bio $ 90M to partner on cancer drugs that make cold tumors hot

Astellas pays Sutro Bio $ 90M to partner on cancer drugs that make cold tumors hot

Astellas Pharma already has a piece of the market for antibody drug conjugates (ADCs), a type of cancer therapy that has seen a surge in progress in recent years. The Japanese pharmaceutical giant co-developed Padcev, which has approvals in bladder cancer, under a partnership with US biotech Seagen. Astellas wants to take the targeted approach … Read more

Tips for tailoring eConsent for optimal patient centricity

Tips for tailoring eConsent for optimal patient centricity

Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number one factor contributing to this figure. Additionally, according to Advarra, “35% of patients who dropped out of a study early reported that it was difficult to understand the … Read more

Nomad Health raises $ 105M to support push into new staffing markets

Nomad Health raises $ 105M to support push into new staffing markets

Nomad Health plans to apply its technology-based staffing model to more jobs in healthcare after raising $ 105 million in equity and debt and hiring a top marketing executive. Announced this week, the funding round was led by Adams Street Partners and Icon Ventures and included participation from a new investor, HealthQuest Capital. The round … Read more

Socially Determined is expanding its client base with a $ 26M boost

Socially Determined is expanding its client base with a $ 26M boost

Providers and payers have a steadfast mission to care for patients and communities, but they are often carrying out that mission without access to data on the factors that influence healthcare costs and outcomes the most: social determinants of health. Traditionally, healthcare organizations have only had access to clinical and claims data about the patients … Read more

Two for two: Sanofi snares twin European nods for enzyme replacement therapies

Two for two: Sanofi snares twin European nods for enzyme replacement therapies

It’s a big day for Sanofi as the pharmaceutical giant welcomes two European drug approvals, both for rare enzyme deficiencies. One regulatory nod ushers in the first treatment in Europe for a particular disease. The other covers a successor to a blockbuster Sanofi drug — though that approval does not go as far as the … Read more

How can we improve AI for mining data from electronic medical records?

How can we improve AI for mining data from electronic medical records?

Data mining from electronic medical records for clinical registries seems like the ideal task to insert artificial intelligence (AI) technology – automating data mining and freeing up clinically important resources. However, replacing human data abstractors with AI alone has resulted in less-than-desired accuracy and limited confidence in the results. It might be time to rethink … Read more